RxDoctor Payments Data

Antonio Poto, DO

Pain Medicine · Port St Lucie, FLNPI 1982875621

Payments from drug & device makers

$7,032in general payments, 2019–2025

Across 231 payments — averaging $30.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$2K
  • Abbott$2K
  • Nevro Corp.$1K
  • Medtronic$685
  • Vertos Medical, Inc.$496
  • Boston Scientific$394
  • plus $767 from 16 others

What the payments were for

  • Travel & lodging$1402%
  • Food & beverage$4,83069%
  • Education$2,06229%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,032 in reported general payments places this provider in the 70th percentile of 596 pain medicine providers in Florida.

See all pain medicine providers in Florida

Medicare billing

Part B allowed, 2024
$455,937
Medicare patients
408
Services billed
6,634

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate271$194,759
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,565$58,573
OxycontinOxycodone Hcl60$46,362
Oxycodone Hcl1,177$32,009
Fentanyl152$27,919
Hysingla ErHydrocodone Bitartrate24$21,908
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen940$21,189
Morphine Sulfate ErMorphine Sulfate587$16,325
Morphine Sulfate163$5,466
Hydromorphone Hcl194$4,124
Diphenhydramine Hcl12$3,357
Tramadol Hcl365$3,123
Hydromorphone ErHydromorphone Hcl11$1,510
Methadone Hcl98$1,395
Gabapentin25$295

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$137$194,759271 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 596 pain medicine providers in Florida.

Other pain medicine in Port St Lucie

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →